Israel’s Oramed is shortly to commence Phase IIb trials of its oral insulin treatment for both Type 1 and Type 2 diabetes. ORMD-0801 will benefit diabetics currently using injections.
http://www.oramed.com/oramed-submits-protocol-to-u-s-fda-for-its-phase-iib-oral-insulin-study/